DUXAP10 and hepatocellular carcinoma: In addition to potentially promoting HCC tumorigenesis, the two upregulated ncRNAs, especially the lncRNA DUXAP10, in the exosome of HCC patients may also be potential diagnostic biomarkers for HCC.